CD276 and neoplasm: Srivastava et al. developed ROR1-targeted CAR T cells expressiong synNotch  receptors for epithelial cell adhesion molecules (EpCAM) or B7-H3, which  are expressed on tumor cells but not on normal stromal cells [125].